Topic Systematic review of risk factors for nonadherence and nonpersistence to intravitreal
anti–vascular endothelial growth factor (VEGF) injection therapy for neovascular age-related …

Purpose Intravitreal injection of VEGF inhibitors has become the standard of care for
different macular diseases within the last years resulting in improved visual outcomes …

Intravitreal injections (IVI) of anti–vascular endothelial growth factor (anti–VEGF) agents
have become the most prevalent intraocular procedure as they represent the major …

Importance Visit adherence has been shown to play a significant role in patient health
outcomes. The effect of missing visits on visual acuity (VA) in individuals with neovascular …

Purpose To investigate the adherence rate of neovascular age-related macular
degeneration (nAMD) patients in treat-and-extend (TAE) protocol to their anti-vascular …

Importance Poor adherence or persistence to treatment can be a barrier to optimizing
clinical practice (real-world) outcomes to intravitreal injection therapy in patients with …

Wet Age-Related Macular Degeneration: Treatment Advances to Reduce the Injection Burden
Page 1 THE AMERICAN JOURNAL OF MANAGED CARE® Supplement VOL. 26, NO. 5 S103 …

Background Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections play a
key role in treating a range of macular diseases. The effectiveness of these therapies is …

Purpose The COVID-19 pandemic affected medical practice worldwide due to interventions
to prevent spreading. Its effect on ophthalmology practices in Latin America has not yet been …

Introduction Timely anti-vascular endothelial growth factor (VEGF) treatment is crucial for
visual function in neovascular age-related macular degeneration (nAMD). The aim of this …